Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study

Open access
Friedman, Deborah M., Kim, Mimi Y., Copel, Joshua A., Llanos, Carolina, Davis, Claudine, Buyon, Jill P. · 2009 · The American Journal of Cardiology

Abstract

To evaluate the efficacy of dexamethasone (DEX) in anti-SSA/Ro–exposed fetuses newly diagnosed with congenital heart block (CHB). Previous use of DEX has been anecdotal with varying reports of therapeutic benefit. Multicenter open label study non-randomized involving 30 pregnancies treated with DEX (22-3rd degree; 6-2nd degree; 2-1st degree) and 10 untreated (9-3rd degree;1-1st degree). Initial median ventricular rates, age at diagnosis, and degree of cardiac dysfunction were similar between groups. Six deaths occurred in the DEX group. There was no reversal of 3rd degree block, with therapy or spontaneously. In fetuses treated with DEX, 1/6 with 2nd degree progressed to 3rd degree and three remained in 2nd degree (postnatally-- one paced, two progressed to 3rd); two reverted to normal sinus rhythm (NSR) (postnatally--one progressed to 2nd). DEX reversed both fetuses with 1st degree to NSR by seven days with no regression upon discontinuation. Absent DEX, the one 1st degree detected at 38 wks had NSR at birth (overall stability or improvement 4/8 DEX vs. 1/1 non-DEX). Median gestational birth age was 37 weeks vs. 38 weeks, DEX vs. non-DEX, p=0.019. Prematurity and small for gestational age were restricted to the DEX group. Pacemaker use and growth parameters at birth and one year were similar between groups. In conclusion, these data confirm the irreversibility of 3rd degree block and progression of 2nd to 3rd degree despite DEX. A potential benefit of DEX in reversing 1st or 2nd degree was supported in rare cases, but should be weighed against potential steroid side effects such as growth restriction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2008.12.027

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 197

Metadata

Authors
Friedman, D. M., Kim, M. Y., Copel, J. A., Llanos, C., Davis, C., & Buyon, J. P.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2009-04
Volume
103
Issue
8
Pages
1102-1106
ISSN
0002-9149 (ISSN-L)
OpenAlex
W1967183300
Cited by
197
References
1
FWCI
8.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. https://app.cochat.ai/papers/10.1016/j.amjcard.2008.12.027
The paper
Friedman, D. M., Kim, M. Y., Copel, J. A., Llanos, C., Davis, C., & Buyon, J. P. (2009). Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2008.12.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.